Home LiteratureArticle Details
PMID: 12610194 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women.

Ebbert JO, Yang P, Vachon CM, Vierkant RA, Cerhan JR, Folsom AR, Sellers TA

Abstract

We conducted this study because the duration of excess lung cancer risk among former smokers has been inconsistently reported, doubt has been raised regarding the population impact of smoking cessation, and differential risk reduction by histologic cell type after smoking cessation needs to be confirmed. The Iowa Women's Health Study is a prospective cohort study of 41,836 Iowa women aged 55 to 69 years. In 1986, mailed questionnaires were used to collect detailed smoking history. Age-adjusted lung cancer incidence through 1999 was analyzed according to years of smoking abstinence. Relative risks were estimated using Cox regression analysis. There were 37,078 women in the analytic cohort. Compared with the never smokers, former smokers had an elevated lung cancer risk (relative risk, 6.6; 95% confidence interval, 5.0 to 8.7) up to 30 years after smoking cessation for all former smokers. However, a beneficial effect of smoking cessation was observed among recent and distant former smokers. The risk of adenocarcinoma remained elevated up to 30 years for both former heavier and former lighter smokers. The risk for lung cancer is increased for both current and former smokers compared with never smokers and declines for former smokers with increasing duration of abstinence. The decline in excess lung cancer risk among former smokers is prolonged compared with other studies, especially for adenocarcinoma and for heavy smokers, suggesting that more emphasis should be placed on smoking prevention and lung cancer chemoprevention.

MeSH Terms
Adenocarcinoma/epidemiology,pathology,prevention & control Aged Carcinoma, Small Cell/epidemiology,pathology,prevention & control Carcinoma, Squamous Cell/epidemiology,pathology,prevention & control Cohort Studies Female Humans Iowa/epidemiology Lung Neoplasms/epidemiology,pathology,prevention & control Middle Aged Prospective Studies Risk Reduction Behavior Smoking/adverse effects Smoking Cessation Surveys and Questionnaires
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Ebbert J O
Nicotine Research Center, Division of Community Internal Medicine, Mayo Clinic Cancer Center, Rochester, Minneapolis, MN, USA.
Yang P
Vachon C M
Vierkant R A
Cerhan J R
Folsom A R
Sellers T A
Article Info
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Abbr.
J Clin Oncol
ISSN
0732-183X
Published
2003-03-01
Pages
921-6
Language
English
Region
United States
NLM ID
8309333
Subset
IM
Grants
NCI NIH HHS · R25 CA092049 · United States
NCI NIH HHS · CA39741 · United States
NCI NIH HHS · CA92049 · United States
NCI NIH HHS · CA84354 · United States
NCI NIH HHS · CA80127 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com